Downregulation of Kv1.5 K + channels by the AMP-activated protein kinase

Cellular Physiology and Biochemistry

Volumn 30, Issue 4, 2012, Pages 1039-1050

  Mia, Sobuj ^a   Munoz, Carlos ^a   Pakladok, Tatsiana ^a   Siraskar, Gulab ^a   Voelkl, Jakob ^a   Alesutan, Ioana ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

AMPK; Energy depletion; Ischemia; Kv1.5

Indexed keywords

ADENYLATE KINASE; POTASSIUM CHANNEL KV1.5; UBIQUITIN PROTEIN LIGASE NEDD4;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CHEMOLUMINESCENCE; CONFOCAL MICROSCOPY; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; IMMUNOHISTOCHEMISTRY; NONHUMAN; OOCYTE; PIPIDAE; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; VOLTAGE CLAMP; XENOPUS;

EID: 84870368355     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000341480     Document Type: Article

References (113)

1. + channels in pancreatic beta cells: role, regulation and potential as therapeutic targets. Diabetologia 2003;46:1046-1062. (Pubitemid 37041235)
2. + channels. Role in stimulus-secretion coupling. J Biol Chem 1996;271:32241-32246. (Pubitemid 26422260)
3. + channels in the insulin-secreting cell line INS-1. Pflugers Arch 2001;442:49-56. (Pubitemid 32336825)
4. + current in canine atrial myocytes. Circ Res 2003;93:744-751. (Pubitemid 37288669)
5. + channel in macrophages. J Biol Chem 2006;281:37675-37685. (Pubitemid 46042071)
6. Matzner N, Zemtsova IM, Nguyen TX, Duszenko M, Shumilina E, Lang F: Ion channels modulating mouse dendritic cell functions. J Immunol 2008;181:6803-6809.
7. + channels in dendritic cells by rapamycin. Am J Physiol Cell Physiol 2010;299:C1379-C1385.
8. Almquist J, Wallman M, Jacobson I, Jirstrand M: Modeling the effect of Kv1.5 block on the canine action potential. Biophys J 2010;99:2726-2736.
9. Bielanska J, Hernandez-Losa J, Moline T, Somoza R, Ramon YC, Condom E, Ferreres JC, Felipe A: Voltagedependent potassium channels Kv1.3 and Kv1.5 in human fetus. Cell Physiol Biochem 2010;26:219-226.
10. Gaborit N, Le Bouter S, Szuts V, Varro A, Escande D, Nattel S, Demolombe S: Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. J Physiol 2007;582:675-693. (Pubitemid 47040552)
11. 2+ model: sinus rhythm and chronic atrial fibrillation. Circ Res 2011;109:1055-1066.
12. + channel contributions to the myogenic response in skeletal muscle arterioles. J Appl Physiol 2009;107:389-398.
13. Hald BO, Jacobsen JC, Braunstein TH, Inoue R, Ito Y, Sorensen PG, Holstein-Rathlou NH, Jensen LJ: BK (Ca) and K (V) channels limit conducted vasomotor responses in rat mesenteric terminal arterioles. Pflugers Arch 2012;463:279-295.
14. Sutendra G, Dromparis P, Bonnet S, Haromy A, McMurtry MS, Bleackley RC, Michelakis ED: Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension. J Mol Med (Berl) 2011;89:771-783.
15. + channel from vascular and visceral smooth muscles. Am J Physiol 1994;267:C1231-C1238.
16. Adda S, Fleischmann BK, Freedman BD, Yu M, Hay DW, Kotlikoff MI: Expression and function of voltagedependent potassium channel genes in human airway smooth muscle. J Biol Chem 1996;271:13239-13243. (Pubitemid 26175907)
17. + current in cultured adult human atrial myocytes. Circ Res 1997;80:572-579. (Pubitemid 27137295)
18. Brunner M, Kodirov SA, Mitchell GF, Buckett PD, Shibata K, Folco EJ, Baker L, Salama G, Chan DP, Zhou J, Koren G: In vivo gene transfer of Kv1.5 normalizes action potential duration and shortens QT interval in mice with long QT phenotype. Am J Physiol Heart Circ Physiol 2003;285:H194-H203. (Pubitemid 36736430)
19. + channel current. Circ Res 1993;73:210-216. (Pubitemid 23173072)
20. Snyders DJ, Tamkun MM, Bennett PB: A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expression. J Gen Physiol 1993;101:513-543. (Pubitemid 23123420)
21. Nattel S, Yue L, Wang Z: Cardiac ultrarapid delayed rectifiers: a novel potassium current family o f functional similarity and molecular diversity. Cell Physiol Biochem 1999;9:217-226.
22. Olson TM, Alekseev AE, Liu XK, Park S, Zingman LV, Bienengraeber M, Sattiraju S, Ballew JD, Jahangir A, Terzic A: Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet 2006;15:2185-2191. (Pubitemid 43985509)
23. Billman GE: Vernakalant, a mixed sodium and potassium ion channel antagonist that blocks K (v) 1.5 channels, for the potential treatment of atrial fibrillation. Curr Opin Investig Drugs 2010;11:1048-1058.
24. Eun JS, Kim KS, Kim HN, Park SA, Ma TZ, Lee KA, Kim DK, Kim HK, Kim IS, Jung YH, Zee OP, Yoo DJ, Kwak YG: Synthesis of psoralen derivatives and their blocking effect of hKv1.5 channel. Arch Pharm Res 2007;30:155-160.
25. Friederich P, Pfizenmayer H: The novel Kv1.5 channel blocker vernakalant for successful treatment of newonset atrial fibrillation in a critically ill abdominal surgical patient. Br J Anaesth 2011;107:644-645.
26. + channels and ultrarapidly activating delayed rectifier potassium current. J Pharmacol Exp Ther 2006;317:1054-1063. (Pubitemid 43764108)
27. Peukert S, Brendel J, Pirard B, Strubing C, Kleemann HW, Bohme T, Hemmerle H: Pharmacophore-based search, synthesis, and biological evaluation of anthranilic amides as novel blockers of the Kv1.5 channel. Bioorg Med Chem Lett 2004;14:2823-2827. (Pubitemid 38569744)
28. + channel kv1.5. Circ Res 2009;104:1390-1398.
29. Strutz-Seebohm N, Gutcher I, Decher N, Steinmeyer K, Lang F, Seebohm G: Comparison of potent Kv1.5 potassium channel inhibitors reveals the molecular basis for blocking kinetics and binding mode. Cell Physiol Biochem 2007;20:791-800. (Pubitemid 350059722)
30. Tamargo J, Caballero R, Gomez R, Delpon E: I (Kur)/Kv1.5 channel blockers for the treatment of atrial fibrillation. Expert Opin Investig Drugs 2009;18:399-416.
31. Tian D, Frishman WH: Vernakalant: a new drug to treat patients with acute onset atrial fibrillation. Cardiol Rev 2011;19:41-44.
32. Yang Q, Wang X, Du L, Li M, You Q: Drug discoveries towards Kv1.5 potassium channel. Curr Top Med Chem 2009;9:339-347.
33. 2 -sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol 2008;294:H570-H578. (Pubitemid 351253263)
34. Arvind S, Arivazhagan A, Santosh V, Chandramouli BA: Differential expression of a novel voltage gated potassium channel - Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma. Br J Neurosurg 2012;26:16-20.
35. + channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007;11:37-51. (Pubitemid 46054520)
36. Han Y, Shi Y, Han Z, Sun L, Fan D: Detection of potassium currents and regulation of multidrug resistance by potassium channels in human gastric cancer cells. Cell Biol Int 2007;31:741-747. (Pubitemid 46779089)
37. Ousingsawat J, Spitzner M, Puntheeranurak S, Terracciano L, Tornillo L, Bubendorf L, Kunzelmann K, Schreiber R: Expression of voltage-gated potassium channels in human and mouse colonic carcinoma. Clin Cancer Res 2007;13:824-831. (Pubitemid 46340355)
38. Preussat K, Beetz C, Schrey M, Kraft R, Wolfl S, Kalff R, Patt S: Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas. Neurosci Lett 2003;346:33-36. (Pubitemid 36792187)
39. + channels inhibits adhesion and proliferation of hepatocarcinoma cells. Int J Mol Med 2003;11:261-266.
40. + Channels Kv1.3 and Kv1.5 as Tumor Biomarkers for Cancer Detection and Prevention. Curr Med Chem 2012;19:661-674.
41. Chu X, Tang X, Guo L, Bao H, Zhang S, Zhang J, Zhu D: Hypoxia suppresses KV1.5 channel expression through endogenous 15-HETE in rat pulmonary artery. Prostaglandins Other Lipid Mediat 2009;88:42-50.
42. Towler MC, Hardie DG: AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 2007;100:328-341.
43. Winder WW, Thomson DM: Cellular energy sensing and signaling by AMP-activated protein kinase. Cell Biochem Biophys 2007;47:332-347. (Pubitemid 47339850)
44. Carling D: The role of the AMP-activated protein kinase in the regulation of energy homeostasis. Novartis Found Symp 2007;286:72-81.
45. McGee SL, Hargreaves M: AMPK and transcriptional regulation. Front Biosci 2008;13:3022-3033. (Pubitemid 351589217)
46. Breen DM, Sanli T, Giacca A, Tsiani E: Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochem Biophys Res Commun 2008;374:117-122.
47. Guan F, Yu B, Qi GX, Hu J, Zeng DY, Luo J: Chemical hypoxia-induced glucose transporter-4 translocation in neonatal rat cardiomyocytes. Arch Med Res 2008;39:52-60. (Pubitemid 350192015)
48. Horie T, Ono K, Nagao K, Nishi H, Kinoshita M, Kawamura T, Wada H, Shimatsu A, Kita T, Hasegawa K: Oxidative stress induces GLUT4 translocation by activation of PI3-K/Akt and dual AMPK kinase in cardiac myocytes. J Cell Physiol 2008;215:733-742. (Pubitemid 351632695)
49. 2+ release increases AMPK-dependent glucose uptake in rodent soleus muscle. Am J Physiol Endocrinol Metab 2007;293:E286-E292. (Pubitemid 47105943)
50. Jessen N, Pold R, Buhl ES, Jensen LS, Schmitz O, Lund S: Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles. J Appl Physiol 2003;94:1373-1379. (Pubitemid 36348812)
51. Kim T, Davis J, Zhang AJ, He X, Mathews ST: Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochem Biophys Res Commun 2009;388:377-382.
52. Kohan AB, Talukdar I, Walsh CM, Salati LM: A role for AMPK in the inhibition of glucose-6-phosphate dehydrogenase by polyunsaturated fatty acids. Biochem Biophys Res Commun 2009;388:117-121.
53. Lei B, Matsuo K, Labinskyy V, Sharma N, Chandler MP, Ahn A, Hintze TH, Stanley WC, Recchia FA: Exogenous nitric oxide reduces glucose transporters translocation and lactate production in ischemic myocardium in vivo. Proc Natl Acad Sci U S A 2005;102:6966-6971. (Pubitemid 40675425)
54. Li J, Hu X, Selvakumar P, Russell RR, III, Cushman SW, Holman GD, Young LH: Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle. Am J Physiol Endocrinol Metab 2004;287:E834-E841. (Pubitemid 39382917)
55. Luiken JJ, Coort SL, Koonen DP, Van der Horst DJ, Bonen A, Zorzano A, Glatz JF: Regulation of cardiac longchain fatty acid and glucose uptake by translocation of substrate transporters. Pflugers Arch 2004;448:1-15. (Pubitemid 38657200)
56. MacLean PS, Zheng D, Jones JP, Olson AL, Dohm GL: Exercise-induced transcription of the muscle glucose transporter (GLUT 4) gene. Biochem Biophys Res Commun 2002;292:409-414. (Pubitemid 34694279)
57. Natsuizaka M, Ozasa M, Darmanin S, Miyamoto M, Kondo S, Kamada S, Shindoh M, Higashino F, Suhara W, Koide H, Aita K, Nakagawa K, Kondo T, Asaka M, Okada F, Kobayashi M: Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia. Exp Cell Res 2007;313:3337-3348. (Pubitemid 47284060)
58. Ojuka EO, Nolte LA, Holloszy JO: Increased expression of GLUT-4 and hexokinase in rat epitrochlearis muscles exposed to AICAR in vitro. J Appl Physiol 2000;88:1072-1075. (Pubitemid 30154913)
59. Ota S, Horigome K, Ishii T, Nakai M, Hayashi K, Kawamura T, Kishino A, Taiji M, Kimura T: Metformin suppresses glucose-6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism. Biochem Biophys Res Commun 2009;388:311-316.
60. Park S, Scheffler TL, Gunawan AM, Shi H, Zeng C, Hannon KM, Grant AL, Gerrard DE: Chronic elevated calcium blocks AMPK-induced GLUT-4 expression in skeletal muscle. Am J Physiol Cell Physiol 2009;296:C106-C115.
61. Song H, Guan Y, Zhang L, Li K, Dong C: SPARC interacts with AMPK and regulates GLUT4 expression. Biochem Biophys Res Commun 2010;396:961-966.
62. + -coupled glucose carrier SGLT1 by AMP-activated protein kinase. Mol Membr Biol 2010;27:137-144.
63. Walker J, Jijon HB, Diaz H, Salehi P, Churchill T, Madsen KL: 5-aminoimidazole-4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AMPK. Biochem J 2005;385:485-491. (Pubitemid 40173969)
64. Winder WW, Holmes BF, Rubink DS, Jensen EB, Chen M, Holloszy JO: Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 2000;88:2219-2226. (Pubitemid 30453931)
65. Zheng D, MacLean PS, Pohnert SC, Knight JB, Olson AL, Winder WW, Dohm GL: Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. J Appl Physiol 2001;91:1073-1083. (Pubitemid 32803899)
66. Zygmunt K, Faubert B, MacNeil J, Tsiani E: Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK. Biochem Biophys Res Commun 2010;398:178-183.
67. Foller M, Sopjani M, Koka S, Gu S, Mahmud H, Wang K, Floride E, Schleicher E, Schulz E, Munzel T, Lang F: Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J 2009;23:1072-1080.
68. Hardie DG: The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 2004;117:5479-5487. (Pubitemid 40012195)
69. + channels through Nedd4-2 and causes an epithelial phenotype when mutated. Pflugers Arch 2009;458:713-721.
70. + channel through functional regulation of the ubiquitin ligase Nedd4-2. J Biol Chem 2006;281:26159-26169. (Pubitemid 44401823)
71. Carattino MD, Edinger RS, Grieser HJ, Wise R, Neumann D, Schlattner U, Johnson JP, Kleyman TR, Hallows KR: Epithelial sodium channel inhibition by AMP-activated protein kinase in oocytes and polarized renal epithelial cells. J Biol Chem 2005;280:17608-17616. (Pubitemid 41388995)
72. Hallows KR, Kobinger GP, Wilson JM, Witters LA, Foskett JK: Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells. Am J Physiol Cell Physiol 2003;284:C1297-C1308. (Pubitemid 36457411)
73. Alesutan I, Munoz C, Sopjani M, Dermaku-Sopjani M, Michael D, Fraser S, Kemp BE, Seebohm G, Foller M, Lang F: Inhibition of Kir2.1 (KCNJ2) by the AMP-activated protein kinase. Biochem Biophys Res Commun 2011;408:505-510.
74. + channel KCNQ1/KCNE1 by the AMP-activated protein kinase. Molecular Membrane Biology 2011;28:79-89.
75. Rotin D, Staub O: Nedd4-2 and the regulation of epithelial sodium transport. Front Physiol 2012;3:212.
76. Soundararajan R, Lu M, Pearce D: Organization of the ENaC-regulatory machinery. Crit Rev Biochem Mol Biol 2012;47:349-359.
77. Gasser A, Cheng X, Gilmore ES, Tyrrell L, Waxman SG, Dib-Hajj SD: Two Nedd4-binding motifs underlie modulation of sodium channel Nav1.6 by p38 MAPK. J Biol Chem 2010;285:26149-26161.
78. 2+ -channel Orai1/STIM1 by serum-and glucocorticoid-inducible kinase 1 (SGK1). FASEB J 2011;25:2012-2021.
79. Zhang W, Na T, Wu G, Jing H, Peng JB: Down-regulation of intestinal apical calcium entry channel TRPV6 by ubiquitin E3 ligase Nedd4-2. J Biol Chem 2010;285:36586-36596.
80. Alzamora R, Gong F, Rondanino C, Lee JK, Smolak C, Pastor-Soler NM, Hallows KR: AMP-activated protein kinase inhibits KCNQ1 channels through regulation of the ubiquitin ligase Nedd4-2 in renal epithelial cells. Am J Physiol Renal Physiol 2010;299:F1308-F1319.
81. Krzystanek K, Rasmussen HB, Grunnet M, Staub O, Olesen SP, Abriel H, Jespersen T: Deubiquitylating enzyme USP2 counteracts Nedd4-2-mediated downregulation of KCNQ1 potassium channels. Heart Rhythm 2012;9:440-448.
82. + channels KCNQ2/3 and KCNQ3/5 by serum-and glucocorticoid- regulated kinase-1. Am J Physiol Cell Physiol 2008;295:C73-C80. (Pubitemid 352755791)
83. Guo J, Wang T, Li X, Shallow H, Yang T, Li W, Xu J, Fridman MD, Yang X, Zhang S: Cell surface expression of hERG channels is regulated by caveolin-3 via Nedd4-2. J Biol Chem 2012; in press.
84. Baltaev R, Strutz-Seebohm N, Korniychuk G, Myssina S, Lang F, Seebohm G: Regulation of cardiac shalrelated potassium channel Kv 4.3 by serum-and glucocorticoid-inducible kinase isoforms in Xenopus oocytes. Pflugers Arch 2005;450:26-33. (Pubitemid 40558529)
85. Andersen MN, Krzystanek K, Jespersen T, Olesen SP, Rasmussen HB: AMP-activated protein kinase downregulates Kv7.1 cell surface expression. Traffic 2012;13:143-156.
86. Boehmer C, Laufer J, Jeyaraj S, Klaus F, Lindner R, Lang F, Palmada M: Modulation of the voltage-gated potassium channel Kv1.5 by the SGK1 protein kinase involves inhibition of channel ubiquitination. Cell Physiol Biochem 2008;22:591-600.
87. - cotransporter via the aldosterone-SGK1-Nedd4-2 pathway. J Am Soc Nephrol 2011;22:1707-1719.
88. Palmada M, Dieter M, Speil A, Bohmer C, Mack AF, Wagner HJ, Klingel K, Kandolf R, Murer H, Biber J, Closs EI, Lang F: Regulation of intestinal phosphate cotransporter NaPi IIb by ubiquitin ligase Nedd4-2. and by serum-and glucocorticoid-dependent kinase 1. Am J Physiol Gastrointest Liver Physiol 2004;287:G143-G150. (Pubitemid 38802128)
89. Boehmer C, Palmada M, Rajamanickam J, Schniepp R, Amara S, Lang F: Post-translational regulation of EAAT2 function by co-expressed ubiquitin ligase Nedd4-2 is impacted by SGK kinases. J Neurochem 2006;97:911-921.
90. Dieter M, Palmada M, Rajamanickam J, Aydin A, Busjahn A, Boehmer C, Luft FC, Lang F: Regulation of glucose transporter SGLT1 by ubiquitin ligase Nedd4-2 and kinases SGK1, SGK3, and PKB. Obes Res 2004;12:862-870. (Pubitemid 41127323)
91. Klaus F, Palmada M, Lindner R, Laufer J, Jeyaraj S, Lang F, Boehmer C: Up-regulation of hypertonicityactivated myo-inositol transporter SMIT1 by the cell volume-sensitive protein kinase SGK1. J Physiol 2008;586:1539-1547. (Pubitemid 351404959)
92. Koutsouki E, Lam RS, Seebohm G, Ureche ON, Ureche L, Baltaev R, Lang F: Modulation of human Kv1.5 channel kinetics by N-cadherin. Biochem Biophys Res Commun 2007;363:18-23. (Pubitemid 47430089)
93. + channel Kv1.5 by beta-catenin. Biochem Biophys Res Commun 2012;417:692-696.
94. - co-transporter NKCC2 by AMP-activated protein kinase (AMPK). Biochem J 2007;405:85-93. (Pubitemid 46999928)
95. + -nucleoside cotransporter rCNT1. J Biol Chem 2001;276:27981-27988.
96. Mohamed MR, Alesutan I, Foller M, Sopjani M, Bress A, Baur M, Salama RH, Bakr MS, Mohamed MA, Blin N, Lang F, Pfister M: Functional analysis of a novel I71N mutation in the GJB2 gene among Southern Egyptians causing autosomal recessive hearing loss. Cell Physiol Biochem 2010;26:959-966.
97. Dermaku-Sopjani M, Sopjani M, Saxena A, Shojaiefard M, Bogatikov E, Alesutan I, Eichenmuller M, Lang F: Downregulation of NaPi-IIa and NaPi-IIb Na-coupled phosphate transporters by coexpression of Klotho. Cell Physiol Biochem 2011;28:251-258.
98. Menniti M, Iuliano R, Foller M, Sopjani M, Alesutan I, Mariggio S, Nofziger C, Perri AM, Amato R, Blazer-Yost B, Corda D, Lang F, Perrotti N: 60kDa lysophospholipase, a new Sgk1 molecular partner involved in the regulation of ENaC. Cell Physiol Biochem 2010;26:587-596.
99. Bohmer C, Sopjani M, Klaus F, Lindner R, Laufer J, Jeyaraj S, Lang F, Palmada M: The serum and glucocorticoid inducible kinases SGK1-3 stimulate the neutral amino acid transporter SLC6A19. Cell Physiol Biochem 2010;25:723-732.
100. Eckey K, Strutz-Seebohm N, Katz G, Fuhrmann G, Henrion U, Pott L, Linke WA, Arad M, Lang F, Seebohm G: Modulation of human ether a gogo related channels by CASQ2 contributes to etiology of catecholaminergic polymorphic ventricular tachycardia (CPVT). Cell Physiol Biochem 2010;26:503-512.
101. Boiteux A, Hess B: Design of glycolysis. Philos Trans R Soc Lond B Biol Sci 1981;293:5-22.
102. Lang F, Rehwald W: Potassium channels in renal epithelial transport regulation. Physiol Rev 1992;72:1-32.
103. + exchanger by the AMP-activated protein kinase. Biochem Biophys Res Commun 2010;398:677-682.
104. Becker S, Reinehr R, Graf D, Vom DS, Haussinger D: Hydrophobic bile salts induce hepatocyte shrinkage via NADPH oxidase activation. Cell Physiol Biochem 2007;19:89-98.
105. Bortner CD, Cidlowski JA: The role of apoptotic volume decrease and ionic homeostasis in the activation and repression of apoptosis. Pflugers Arch 2004;448:313-318. (Pubitemid 40895600)
106. Foller M, Kasinathan RS, Duranton C, Wieder T, Huber SM, Lang F: PGE2-induced apoptotic cell death in K562 human leukaemia cells. Cell Physiol Biochem 2006;17:201-210. (Pubitemid 43946276)
107. + loss. Cell Physiol Biochem 2007;20:35-44. (Pubitemid 46956810)
108. Shimizu T, Wehner F, Okada Y: Inhibition of hypertonicity-induced cation channels sensitizes HeLa cells to shrinkage-induced apoptosis. Cell Physiol Biochem 2006;18:295-302. (Pubitemid 44948040)
109. + exchanger activity by parvovirus B19 protein NS1. Cell Physiol Biochem 2009;23:211-220.
110. Lang F, Messner G, Rehwald W: Electrophysiology of sodium-coupled transport in proximal renal tubules. Am J Physiol 1986;250:F953-F962.
111. Lang F, Busch GL, Ritter M, Volkl H, Waldegger S, Gulbins E, Haussinger D: Functional significance of cell volume regulatory mechanisms. Physiol Rev 1998;78:247-306. (Pubitemid 28070981)
112. 2 -sensing cells? J Biol Chem 2005;280:41504-41511. (Pubitemid 41832211)
113. Lira VA, Soltow QA, Long JH, Betters JL, Sellman JE, Criswell DS: Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle. Am J Physiol Endocrinol Metab 2007;293:E1062-E1068. (Pubitemid 47535838)